Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis

BACKGROUND: Clinicopathological studies suggest that Alzheimer's disease (AD) pathology begins ∼10–15 years before the resulting cognitive impairment draws medical attention. Biomarkers that can detect AD pathology in its early stages and predict dementia onset would, therefore, be invaluable f...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Craig-Schapiro, Rebecca, Kuhn, Max, Xiong, Chengjie, Pickering, Eve H., Liu, Jingxia, Misko, Thomas P., Perrin, Richard J., Bales, Kelly R., Soares, Holly, Fagan, Anne M., Holtzman, David M.
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2011
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3079734/
https://ncbi.nlm.nih.gov/pubmed/21526197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0018850
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires